Nice10 Jan 2019 10:40
post by babs
We expect by early 2019 that Alkindi(R) will be commercially available in the UK, Germany, Austria and the Nordic region. We also remain focused on completing pricing negotiations in key European territories as well as the finalisation of the clinical data package for Alkindi(R) in the US for submission to the FDA."